NRC Stock Forecast & Price Target

NRC Health is well positioned by its differentiated, healthcare-specific experience management platform, proprietary dataset, and 45-year operating history, which support strong customer trust and a durable subscription model with 99% recurring revenue. The latest quarter showed the business is re-accelerating, with revenue of $38.4M beating estimates by 7%, EBITDA of $10.9M outperforming expectations, TRCV rising to $154M, and several long-standing customers renewed into multi-year contracts. Its new management team is also improving bookings and retention, while the large customer win now fully implemented in 3Q26 and the expected 4Q margin improvement point to better top-line growth and expanding profitability.

NRC Health is facing a fundamentally fragile setup, as a large industry consolidation may create opportunities but also delay sales cycles, while efforts to reaccelerate Insights and TGI may fail to offset slowing demand. Its cost structure and capital allocation look pressured, with SG&A at about 40% of revenue in 2025, non-core adjusted SG&A still around 31%, and management at risk of using more cash for dividends and buybacks than it generates, increasing leverage. The outlook is further weakened by competition from scaled research and human experience vendors, plus thin liquidity from a 12M-share float and under-125K average 90-day trading volume that can magnify volatility.